(Press-News.org) The downed limbs and other woody debris that are inevitable byproducts of timber harvest could be among the most important components of post-harvest landscapes, according to a new study led by the U.S. Forest Service's Pacific Northwest Research Station.
Researchers found that retaining moderate levels of logging debris, also known as "slash," helped to both directly and indirectly increase the growth rate of Douglas-fir seedlings replanted after harvest. The findings, which are among the first to speak to the benefits of second-growth logging debris, are published online in the journal Forest Ecology and Management.
"At levels typically left after forest harvesting, where 40 percent of the ground is covered by logging debris, we found that debris inhibited the growth of competing herbaceous vegetation and so preserved soil water," said Tim Harrington, a research forester with the station and the study's lead. "This means that just leaving typical levels of debris in place after forest harvesting helps new Douglas-fir seedlings to become established."
The findings are based on a study of seedling development under three levels of logging debris—0, 40, and 80 percent cover—at two sites in Washington and Oregon affiliated with the North American Long-Term Soil Productivity study, a collaborative program launched by Forest Service Research and Development more than two decades ago. Harrington and his colleagues expanded on previous research on logging debris effects by increasing the number of seedlings studied, extending the study period to four years, and looking at the responses of additional variables, like vegetation abundance and seedling water potential.
In addition to having a "vegetation control" effect, the retained woody debris helped promote Douglas-fir seedling growth by reducing evaporation; slowing decomposition and allowing soil carbon and other nutrients to accumulate; and inhibiting the invasion of aggressive, non-native species, including Scotch broom and hairy cat's ear.
These responses occurred where no herbicide treatments were applied. However, where the use of herbicides to control competing vegetation was combined with logging debris, seedling growth rates were the highest observed in the study, especially where debris cover was 80 percent.
"Industrial forest managers and private landowners in Washington and Oregon are already using early results of the study to prevent Scotch broom invasions," Harrington said. "But these new findings suggest that long-term forest productivity will benefit from debris retention, indicating much broader applicability of the research," Harrington said.
### The study was conducted in collaboration with Robert Slesak, University of Minnesota; and Stephen Schoenholtz, Virginia Tech. It will appear in print in a forthcoming issue of the journal.
The Pacific Northwest Research Station—headquartered in Portland, Ore.—generates and communicates scientific knowledge that helps people make informed choices about natural resources and the environment. The station has 11 laboratories and centers located in Alaska, Oregon, and Washington and about 390 employees. Learn more online at http://www.fs.fed.us/pnw.
Logging debris gives newly planted Douglas-fir forests a leg-up
Retaining moderate levels of 'slash' linked to increased early growth in seedlings
2013-03-12
ELSE PRESS RELEASES FROM THIS DATE:
Drug may improve outcomes after heart attack
2013-03-12
SAN FRANCISCO (March 10, 2013) — The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
The REMINDER (Reduction of heart failure morbidity in patients with acute ST-elevation myocardial infarction) trial was a randomized, double-blind trial of 1,012 patients who had a heart attack caused by a complete blockage of one of the heart's arteries. Patients had no signs or ...
Investigational drug reduces heart damage during angioplasty
2013-03-12
SAN FRANCISCO (March 10, 2013) — A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
More than 1 million coronary angioplasty procedures are performed in the United States each year, at a cost of more than $10 billion. Heart tissue can be damaged during angioplasty, often leading to additional procedures, poor outcomes and higher health care costs.
In this trial, researchers compared a single dose of ...
Clot-busting drug as effective as angioplasty
2013-03-12
SAN FRANCISCO (March 10, 2013) — A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
"Drug therapy before transfer is at least as effective as [angioplasty], and an urgent catheterization was avoided in two-thirds of patients," said Frans Van de Werf, MD, PhD, professor of cardiology at University of Leuven, Belgium, and the study's lead investigator.
"It gives [clinicians] time to consider other options, such ...
Drug reduces chest pain in patients with diabetes
2013-03-12
SAN FRANCISCO (March 10, 2013) — A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both as first line therapy and as an add-on when symptoms are not relieved with other anti-anginal drugs, including beta-blockers, calcium channel ...
High-dose oral vitamins, minerals do not reduce recurrent cardiac events in heart attack patients
2013-03-12
SAN FRANCISCO (March 10, 2013) — Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. However, the results of one component of the NIH-funded Trial to Assess Chelation Therapy (TACT) study, shows that when combined with active chelation therapy, high-dose vitamins and minerals may provide some additional benefit.
The TACT study tested the safety and effectiveness of ...
Digoxin reduces hospital admissions in older patients with chronic heart failure
2013-03-12
SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Researchers reviewed patient outcomes from 1995 in the Digitalis Investigation Group (DIG) trial of 6,800 patients with HFrEF—a condition in which the heart is too weak to pump and patients suffer from breathlessness and fatigue. Patients with HFrEF ...
Clot-busting drug benefits intermediate-risk patients with pulmonary embolism
2013-03-12
SAN FRANCISCO (March 11, 2013) — The clot-busting drug tenecteplase prevents death or circulatory collapse in a subgroup of patients with a blood clot in the lungs and appears to be especially useful in patients younger than 75, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Pulmonary embolism occurs when part of a blood clot in a vein breaks off and travels to the lungs. It is fatal about 10 percent of the time, killing between 60,000 and 100,000 Americans each year. The most common cause of death is progressive ...
Screenings, targeted care reduce heart failure in at-risk patients
2013-03-12
SAN FRANCISCO (March 11, 2013) — For at-risk patients, a simple screening and management program can be effective in preventing heart failure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
The five-year STOP-HF study enrolled asymptomatic patients over 40 years of age with risk factors for heart failure and randomized them into an intervention and a control group. Patients in the intervention group were screened for blood levels of B-type natriuretic peptide (BNP), a hormone that indicates how well the heart ...
No benefit found from BP drug in treatment of recently hospitalized heart failure patients
2013-03-12
SAN FRANCISCO (March 11, 2013) —Despite high hopes that a blood pressure-lowering medication called aliskiren would help people following hospitalization for heart failure, no beneficial effects were found, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Heart failure is the leading cause of hospitalization for people over age 65, costing Medicare billions of dollars annually, and researchers are always on the lookout for more effective treatments.
The Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) ...
Erectile dysfunction drug fails for diastolic heart failure patients
2013-03-12
SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
The RELAX Study is the first multicenter trial to look at the effect of chronic therapy with sildenafil in diastolic heart failure. Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor, a class of drugs used to treat erectile dysfunction and certain types of pulmonary arterial hypertension. ...
LAST 30 PRESS RELEASES:
Graz University of Technology and the University of Regensburg carry out research on the link between leaky blood-brain barrier and depression
Conversation analysis reveals how teacher educators shape reflection through feedback
Why deep sighs are actually good for us
Unexpected discovery on Saturn's moon challenges our view on chemistry before life emerged
The European project to reduce the number of animals used in experimentation, VICT3R, adds new partners and increases its budget to €30 million
New clinical trial to advance seizure monitoring and improve epilepsy diagnosis
Sniffer dogs tested in real-world scenarios reveal need for wider access to explosives, study finds
Ex-smokers who relapse may simply be tired of the effort of not smoking
A better way to monitor drug therapy at home
Rare earth engineering to mitigate corrosion challenges in seawater electrolysis
MXene‑based wearable contact lenses: Integrating smart technology into vision care
Unlocking the power of gold: a breakthrough in green chemistry
Ru-Co single-atom alloy catalysts for efficient amination of alcohols
Biochar shows big promise for climate-friendly soil management
New biochar innovation captures stubborn metal pollutants from water
New blood test shows promise in detecting ALS early
Combination of pre- and probiotics offers superior anti-inflammatory benefits compared with omega-3 or prebiotic alone
Walking, cycling and swimming likely best exercise for knee osteoarthritis
SGLT-2 diabetes drugs linked to lower risk of autoimmune diseases
Imposter study participants risk undermining patient care, warn experts
Ants alter their nest networks to prevent epidemics, study finds
Indian literary genius survived British imperialism in forgotten villages, research reveals
Longevity gene from supercentenarians offers hope for disease that causes rapid aging in children
Climate change drove extreme wildfire seasons across the Americas, making burned areas around 30 times larger
Gene therapy delivers lasting immune protection in children with rare disorder
New world record set for fastest human whole genome sequencing, representing significant step towards revolutionizing genomic care in the NICU
Shedding light on materials in the physical, biological sciences
Study finds emotional tweets by politicians don’t always win followers and can backfire with diverse audiences
Paul “Bear” Bryant Awards announce 2025 Coach of the Year Award watch list
$3 million National Institute on Aging grant will provide much-needed support to underserved dementia caregivers
[Press-News.org] Logging debris gives newly planted Douglas-fir forests a leg-upRetaining moderate levels of 'slash' linked to increased early growth in seedlings